SANA Sana Biotechnology, Inc.: Projected Price to Earnings

Corporate company logo of Sana Biotechnology, Inc. (SANA)

Sana Biotechnology creates hypoimmune cells for rejection-free transplants within a high scientific risk zone. The company's forward P/E valuation trend helps hedge risks, with the parameter reaching 0.00. Patents for "invisible" cells create a powerful barrier in allogeneic therapy, while strict cryopreservation control during transport guarantees drug viability.

sana.com - SANA Future Price to Earnings Multiple (period 07/04/2022 - 11/15/2026)

Summary analytical data breakdowns for sana.com (SANA)

- stock quotes and analyst forecast:
Stock Price Sana Biotechnology Inc|SANA - Analyst Target Range
- company stock capitalization data:
Market Valuation Sana Biotechnology Inc|SANA - Total Enterprise Value
- issuer book value statistics:
Accounting Value per Share Sana Biotechnology|SANA - Accounting Value of Company|Market Capitalization to Book Value Ratio sana.com|SANA - Cumulative Company Assets
- debt level and financial liquidity data:
Total Debt to Capital Sana Biotechnology|SANA - Long-Term Liabilities to Capital|Short-Term Debt to Equity Sana Biotechnology, Inc.|SANA - Company Debts|Debt to Book Capitalization Ratio Sana Corp|SANA - Company Long-Term Debt|Company Current Liabilities Sana Biotechnology|Quick Ratio sana.com
- financial results and valuation multiples details:
SANA - Annual Net Income|Projected Future Earnings Sana Biotechnology|SANA - Market Cap to Earnings|Future Price to Earnings Sana Biotechnology, Inc.|SANA - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Sana Biotechnology Inc|SANA - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Sana Biotechnology|SANA - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months sana.com|SANA - Net earnings per one share growth for the current year|Earnings growth forecast for next year Sana Biotechnology
- sales volume and revenue information:
SANA - Company Sales Revenue|Projected Sales Volume sana.com|SANA - Price to Sales|Price-to-Projected Revenue Ratio Sana Biotechnology|SANA - Revenue Dynamics YoY (Last Twelve Months)
General company analysis:SANA Sana Bio
Brand item of Sana Biotechnology

Sana Biotechnology (SANA) is a high-tech biotech asset with a capital-intensive development model. The trend in the company's forward P/E ratio reflects market expectations regarding future earnings. This multiple compares the business's market value with the expected earnings per share. Outsourcing production and research reduces operating expenses, directly impacting the calculated yield. The stability of this indicator confirms the fundamental resilience of the company's strategy.

Competing companies

Forward P/E Multiple LEGN|Autolus Therapeutics (AUTL) - Forward Price to Earnings Multiple|Allogene Therapeutics, Inc. - Projected Price to Earnings|Cartesian Therapeutics, Inc. (RNAC) - Projected Price to Earnings Ratio|CLLS: Projected Price to Earnings|Future Price to Earnings Multiple CRBU (Caribou Biosciences, Inc.)|TIL: Forward P/E Multiple|Projected Price to Earnings Genenta Science SpA|IPSC (Century Tx) - Forward P/E Multiple|Projected Price to Earnings Ratio jaspertherapeutics.com JSPR|Future Price to Earnings Senti Biosciences (SNTI)|Future Price to Earnings ADAP (Adaptimmune Therapeutics plc)|Future Price to Earnings CERo Therapeutics Holdings Inc. CERO|alaunos.com - Future Price to Earnings|ACHL: Projected Price to Earnings|Future Price to Earnings Multiple CRGX (CARGO Therapeutics)|PSTX: Forward P/E Multiple|Forward Price to Earnings Multiple 2seventy bio TSVT|GRCL (gracellbio.com) - Forward P/E Multiple